| # | Title | Journal | Year | Citations |
|---|
| 1 | Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 19 |
| 2 | COVID-19 and diabetes: A bidirectional relationship | Clínica E Investigación En Arteriosclerosis (English Edition) | 2021 | 19 |
| 3 | Influence of the microbiota and probiotics in obesity | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 15 |
| 4 | Dyslipemias and pregnancy, an update | Clínica E Investigación En Arteriosclerosis (English Edition) | 2021 | 12 |
| 5 | Osteoporosis and vascular calcification: A shared scenario | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 11 |
| 6 | Sedentarism, a disease from xxi century | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 10 |
| 7 | Adhesion to the Mediterranean diet in diabetic patients with poor control | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 8 |
| 8 | Mediterranean diet, weight status and physical activity in schoolchildren of the Region of Murcia | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 7 |
| 9 | Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosis | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 6 |
| 10 | Chronic kidney disease and dyslipidaemia | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 6 |
| 11 | Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study) | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 6 |
| 12 | Mitochondrial oxidative stress and cardiac ageing | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 6 |
| 13 | Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Society of Arteriosclerosis (SEA), 2019 | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 6 |
| 14 | Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 6 |
| 15 | Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®) | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 6 |
| 16 | Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 6 |
| 17 | Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 5 |
| 18 | Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 5 |
| 19 | Document of recommendations of the SEA 2018. Lifestyle in cardiovascular prevention | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 5 |
| 20 | Atherosclerosis and clonal hematopoiesis: A new risk factor | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 5 |
| 21 | Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 4 |
| 22 | Past, present and future of pharmacotherapy for obesity | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 4 |
| 23 | Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 4 |
| 24 | Nitric oxide and related factors linked to oxidation and inflammation as possible biomarkers of heart failure | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 4 |
| 25 | Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 4 |
| 26 | Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular disease | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 4 |
| 27 | Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 4 |
| 28 | Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines | Clínica E Investigación En Arteriosclerosis (English Edition) | 2021 | 4 |
| 29 | Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 3 |
| 30 | Nanotechnology, a new paradigm in atherosclerosis treatment | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 3 |
| 31 | Vascular lysyl oxidase over-expression alters extracellular matrix structure and induces oxidative stress | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 3 |
| 32 | Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 3 |
| 33 | An increase in epicardial fat in women is associated with thrombotic risk | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 3 |
| 34 | Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 3 |
| 35 | Pathophysiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 3 |
| 36 | Update of therapeutic planning tables oriented towards obtaining therapeutic objectives | Clínica E Investigación En Arteriosclerosis (English Edition) | 2019 | 3 |
| 37 | Vitamin D-mitochondria cross-talk could modulate the signalling pathway involved in hypertension development: a translational integrative overview | Clínica E Investigación En Arteriosclerosis (English Edition) | 2020 | 3 |
| 38 | Annexins: Involvement in cholesterol homeostasis, inflammatory response and atherosclerosis | Clínica E Investigación En Arteriosclerosis (English Edition) | 2021 | 3 |
| 39 | Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway | Clínica E Investigación En Arteriosclerosis (English Edition) | 2021 | 3 |
| 40 | Familial hypercholesterolemia in childhood and adolescents: A hidden reality | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 41 | Vascular lesions in patient with Takayasu arteritis and massive elevated lipoprotein (a) levels. Residual involvement or premature aterosclerosis? | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 42 | Statin associated myopathy in clinical practice. Results of DAMA study | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 43 | Advanced oxidation protein products and their relationship with cardiovascular risk factors in young apparently healthy people | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 44 | Effect of an individualised physical exercise program on lipid profile in sedentary patients with cardiovascular risk factors | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 45 | Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 46 | New mechanisms of vascular fibrosis: Role of lysyl oxidase | Clínica E Investigación En Arteriosclerosis (English Edition) | 2017 | 2 |
| 47 | Homogenization of the lipid profile values | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 2 |
| 48 | Epistasis analysis of metabolic genes polymorphisms associated with ischemic heart disease in Yucatan | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 2 |
| 49 | Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 2 |
| 50 | Influence of a physical exercise programme on VO 2 max in adults with cardiovascular risk factors | Clínica E Investigación En Arteriosclerosis (English Edition) | 2018 | 2 |
